<DOC>
	<DOC>NCT01445964</DOC>
	<brief_summary>An open-label, single-dose, three-treatment, three-period study to investigate the effect of SLCO2B1 genotype and apple juice on pharmacokinetics of atenolol after oral administration in healthy male Korean.</brief_summary>
	<brief_title>Effect of SLCO2B1 Genotype and Apple Juice on Pharmacokinetics of Atenolol After Oral Administration in Healthy Male Korean</brief_title>
	<detailed_description />
	<mesh_term>Atenolol</mesh_term>
	<criteria>Subject is informed of the investigational nature of this study and voluntarily agrees to participate in this study and signs an Institutional Review Board (IRB) approved informed consent prior to performing any of the screening procedures A subject with history of allergies including study drug (atenolol) or other drug allergies (aspirin, antibiotics, etc.), or history of clinically significant allergies</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>SLCO2B1 genotype</keyword>
	<keyword>effect of apple juice</keyword>
</DOC>